Soft tissue sarcoma accounts for only about 1% of adult cancers overall, but its age-adjusted incidence nearly triples after age 70, rising to roughly 18.2 per 100,000 compared with 5.9 per 100,000 in the general population, and roughly 60% of cases occur in patients 65 and older. With more than 50 biologically distinct subtypes each carrying its own treatment pathway, precise histotype- and site-specific coding is central to representing the true complexity of this disease in an aging population.
AAVBC's Soft Tissue Sarcoma Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering HCC/RAF V28 mapping, Medicare screenings and surveillance, geriatric risk factors, diagnostic thresholds including AJCC 8th edition staging and FNCLCC grading, comorbidity screening, MEAT documentation standards, NCCN-aligned treatment by stage and histotype, referral criteria, and coding specificity with case examples. Grounded in current NCCN and AJCC guidance, this guide supports consistent, individualized clinical decision-making, helping care teams recognize red-flag presentations early, document histotype and site specificity, and coordinate care with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of soft tissue sarcoma — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Soft tissue sarcoma accounts for only about 1% of adult cancers overall, but its age-adjusted incidence nearly triples after age 70, rising to roughly 18.2 per 100,000 compared with 5.9 per 100,000 in the general population, and roughly 60% of cases occur in patients 65 and older. With more than 50 biologically distinct subtypes each carrying its own treatment pathway, precise histotype- and site-specific coding is central to representing the true complexity of this disease in an aging population.
AAVBC's Soft Tissue Sarcoma Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering HCC/RAF V28 mapping, Medicare screenings and surveillance, geriatric risk factors, diagnostic thresholds including AJCC 8th edition staging and FNCLCC grading, comorbidity screening, MEAT documentation standards, NCCN-aligned treatment by stage and histotype, referral criteria, and coding specificity with case examples. Grounded in current NCCN and AJCC guidance, this guide supports consistent, individualized clinical decision-making, helping care teams recognize red-flag presentations early, document histotype and site specificity, and coordinate care with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of soft tissue sarcoma — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
